Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 46.10
-1.60 (-3.35%)
Mar 26, 2026, 1:30 PM CST
Orient EuroPharma Revenue
In the year 2025, Orient EuroPharma had annual revenue of 4.60B TWD with 4.64% growth. Orient EuroPharma had revenue of 1.20B in the quarter ending December 31, 2025, with 5.62% growth.
Revenue
4.60B
Revenue Growth
+4.64%
P/S Ratio
0.87
Revenue / Employee
13.55M
Employees
339
Market Cap
4.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.60B | 203.80M | 4.64% |
| Dec 31, 2024 | 4.39B | -200.59M | -4.37% |
| Dec 31, 2023 | 4.59B | -138.56M | -2.93% |
| Dec 31, 2022 | 4.73B | -36.57M | -0.77% |
| Dec 31, 2021 | 4.77B | -616.63M | -11.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Formosa Laboratories | 4.85B |
| Maywufa Company | 1.58B |
| Orient Pharma | 1.40B |
| SCI Pharmtech | 1.34B |
| TSH Biopharm Corporation | 1.34B |
| Allied Biotech | 849.51M |
| Easywell Biomedicals | 597.41M |
| Johnson Chemical Pharmaceutical Works | 569.77M |